| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.03 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.066 | 0.04 |